Allogeneic haematopoietic cell transplantation for myelofibrosis: proposed definitions and management strategies for graft failure, poor graft function and relapse: best practice recommendations of the EBMT Chronic Malignancies Working Party - McLornan, Donal P.; Hernandez-Boluda, Juan Carlos; Czerw, Tomasz; Cross, Nicholas; Joachim Deeg, H.; Ditschkowski, Marcus; Moonim, Mufaddal T.; Polverelli, Nicola; Robin, Marie; Aljurf, Mahmoud; Conneally, Eibhlin; Hayden, Patrick; et al. (Leukemia, 2021)
Keywords: 692/699/1541; 692/699/1541/1990/2331; Adoptive immunotherapy; Best practice; Cancer Research; Care and treatment; Chimerism; Complications; Critical Care Medicine; Development and progression; Disease Management; Failure; Graft rejection; Graft Rejection - etiology; Graft Rejection - pathology; Graft Rejection - prevention & control; Graft vs Host Disease - etiology; Graft vs Host Disease - metabolism; Graft vs Host Disease - prevention & control; Grafting; Grafts; Hematology; Hematopoietic Stem Cell Transplantation - adverse effects; Humans; Immunotherapy; Inflammation; Intensive; Internal Medicine; Life Sciences; Medicine; Medicine & Public Health; Myelofibrosis; Oncology; Palliation; Practice Guidelines as Topic - standards; Primary Myelofibrosis - pathology; Primary Myelofibrosis - therapy; Recurrence; Review Article; Splenomegaly; Stem cells; Transplantation; Transplantation, Homologous; Transplants & implants; United Kingdom